Concepedia

Author

Antoine Italiano

Institut Bergonié

Also Known As

A Italiano, A. Italiano, Antoine Italiano

66

Publications

550

Citations

11

H-Index

18

Concepts

All Affiliations

Institut BergoniéUniversité de BordeauxInstitut Gustave RoussyInsermBayer (Italy)
AI

About

Antoine Italiano is an author at Institut Bergonié specializing in oncology, radiation oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

109

2

Pathology

2

2

95

3

Cell Biology

1

1

10

4

Gastroenterology

1

1

85

5

Immunology

1

1

14

Antoine Italiano

×

9

Publications

295

Citations

9

H-Index

YearCitations

Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas

Carlo Lucchesi, Emmanuel Khalifa, Yec’han Laizet,

JAMA Oncology

2018

96

Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting

Stéphane Bouchet, Sylvie Poulette, Karine Titier,

European Journal of Cancer

2016

85

Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

Florent Peyraud, Jean-Philippe Guégan, Christophe Rey,

Cell Reports Medicine

2025

26

Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis

M. Debaudringhien, Jean‐Yves Blay, A.M. Bimbai,

ESMO Open

2022

19

Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response

Jean-Philippe Guégan, Florent Peyraud, Bérengère Dadone‐Montaudié,

Cell Reports Medicine

2024

19

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer

Changsong Qi, Lin Shen, Thierry André,

European Journal of Cancer

2025

16

1313MO Safety and preliminary efficacy of AZD7789, a bispecific antibody targeting PD-1 and TIM-3, in patients (pts) with stage IIIB–IV non-small-cell lung cancer (NSCLC) with previous anti-PD-(L)1 therapy

Benjamin Besse, Antoine Italiano, Sophie Cousin,

Annals of Oncology

2023

14

Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

Céline Auzanneau, Delphine Bacq, Carine Bellera,

ESMO Open

2020

10

SO-31 Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset

Elena Garralda, David S. Hong, Renjie Xu,

Annals of Oncology

2022

10

Page 1